The "Elevate" by MAPS Podcast

Objectives: At the end of this series of podcasts, the participant should be able to:Discuss the functions and activities of key internal partnersIdentify potential areas for compliant collaboration by MSLs with key internal partners

The objective of this podcast is to discuss how the 21st Century Cures Act has led to new initiatives at FDA involving Real World Evidence.  We will also examine some case studies where biopharma and medical device companies used Real World Evidence in innovative manners to obtain product regulatory approvals.  

In this MAPS podcast, we speak with Luca Dezzani, Franchise Head Immuno-Oncology, AstraZeneca and Bruno Larvol, CEO and founder of LARVOL, about the emerging uses of social media in the practice of Medical Affairs including best practices and compliance concerns for Medical Affairs professionals participating in the social media landscape. 

Objectives: At the end of this series of podcasts, the participant should be able to:·         Discuss the functions and activities of key internal partners·         Identify potential areas for compliant collaboration by MSLs with key internal partnersModerator: Kathryn Gann, PhD, Independent ConsultantInterviewer: Robert Groebel, VP, Global Medical Strategy, MonoclSpeaker: Ricardo Maamari, MD, NCMP, Global Medical Executive Director, Established/Optimized Portfolio and Rare Diseases, Novartis

The podcast objectives are to : ·      Discuss some of the common challenges Medical Affairs organizations face in offering best-in-class digital capabilities to its customers.·      Offer some insights and perspectives both internally and externally to understand what opportunities exist to overcome these challenges.

Objectives: At the end of this series of podcasts, the participant should be able to:Discuss the functions and activities of key internal partnersIdentify potential areas for compliant collaboration by MSLs with key internal partnersModerator: Kathryn Gann, Independent ConsultantInterviewer: Donna Holder, PharmD, Senior Director, Global MSL Excellence, Daiichi Sankyo, Inc, Speaker: Mary Beth DeYoung PhD, Publications Lead, AstraZeneca

The podcast objectives are to : Discuss some of the common challenges Medical Affairs organizations face in offering best-in-class digital capabilities to its customersOffer some insights and perspectives both internally and externally to understand what opportunities exist to overcome these challenges.Moderator: Rishi Ohri, MBA, MS, Sr. Director MA Digital Excellence, Astellas PharmaInterviewee: Jonathan Davies, MSc, Vice President Operational Excellence, Medical Affairs, Astellas Pharma

 At the end of this series of podcasts, the participant should be able to:·         Discuss the functions and activities of key internal partners·         Identify potential areas for compliant collaboration by MSLs with key internal partners

The podcast objectives are to : ·      To discuss some of the common challenges Medical Affairs organizations face in offering best-in-class digital capabilities to its customers.·      To offer some insights and perspectives both internally and externally to understand what opportunities exist to overcome these challenges.Moderator: Rishi Ohri, MBA, MS, Sr. Director MA Digital Excellence, Astellas PharmaInterviewee: Robert Stevens, Vice President & Global Head, Digital Medical Affairs, Novartis Pharma AG

Objectives: At the end of this series of podcasts, the participant should be able to:·         Discuss the functions and activities of key internal partners·         Identify potential areas for compliant collaboration by MSLs with key internal partnersModerator: Kathryn Gann, Independent ConsultantInterviewer: Amanda Logue, Oncology, Global MSL Excellence Director, AstraZenecaPaul Naish, Director, UK Policy, AstraZeneca